Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
6.97
-0.34 (-4.65%)
At close: Oct 30, 2026, 4:00 PM EDT
6.95
-0.02 (-0.29%)
After-hours: Oct 30, 2026, 7:52 PM EDT
Ocular Therapeutix Employees
Ocular Therapeutix had 325 employees as of December 31, 2025. The number of employees increased by 51 or 18.61% compared to the previous year. That makes Ocular Therapeutix the 23,270th largest employer in the world and 2,999th in the United States.
Employees
325
Change (1Y)
51
Growth (1Y)
18.61%
Revenue / Employee
$160,169
Profits / Employee
-$927,529
Market Cap
1.53B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 325 | 51 | 18.61% |
| Dec 31, 2024 | 274 | 7 | 2.62% |
| Dec 31, 2023 | 267 | -7 | -2.55% |
| Dec 31, 2022 | 274 | 46 | 20.18% |
| Dec 31, 2021 | 228 | 47 | 25.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Immunocore Holdings | 524 |
| Replimune Group | 465 |
| Nuvation Bio | 305 |
| UroGen Pharma | 300 |
| Structure Therapeutics | 281 |
| Innoviva | 159 |
| AnaptysBio | 104 |
OCUL News
- 3 days ago - Ocular Therapeutix™ to Participate in November Investor and Scientific Conferences - GlobeNewsWire
- 12 days ago - Ocular Therapeutix management to meet with Piper Sandler - TheFly
- 12 days ago - Ocular Therapeutix Transcript: Chardan's 10th Annual Healthcare Conference - Transcripts
- 17 days ago - Ocular Therapeutix Slides: Investor presentation - Filings
- 21 days ago - Ocular Therapeutix initiated with a Buy at UBS - TheFly
- 23 days ago - Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Ocular Therapeutix Slides: Investor presentation - Filings
- 4 weeks ago - Ocular Therapeutix™ to Participate in October Scientific and Investor Conferences - GlobeNewsWire